ISTH/X
Jul 16, 2025, 14:57
ISTH SSC Launches Survey on Antithrombotic Therapy in Brain Tumor Patients
The International Society on Thrombosis and Haemostasis (ISTH) Scientific and Standardization Committee (SSC) shared a post on X:
“Are you an expert in neurosurgery or antithrombotic therapy? Take our 15-min survey on managing brain tumor patients with ICH + anticoagulation needs.”
Participate in the survey and contribute to the development of future clinical guidance.
Stay connected for more updates in thrombosis care at Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis